AWM Investment Company
NEW YORK, NYfiles as AWM Investment Company, Inc.
$1.2bn in 106 US stocks at the end of 30 June 2026. The top 10 are 37.3% of the money. It changed about 22.3% of the portfolio this quarter.
Value
$1.2bn
Stocks
106
Top 10 share
37.3%
Turnover
22.3%
What changed this quarter
New
Bought for the first time this quarter.
- Boost RunBRUN2.7% of the fund
- Amtech SystemsASYS1.4% of the fund
- SOPHiA GENETICS SASOPH0.9% of the fund
- SCHMID GroupSHMD0.8% of the fund
- Spruce BiosciencesSPRB0.7% of the fund
- LantronixLTRX0.6% of the fund
- Elmet GroupELMT0.6% of the fund
- Mayville Engineering CompanyMEC0.6% of the fund
- Lifeway FoodsLWAY0.6% of the fund
- NeoVoltaNEOV0.4% of the fund
- Aura BiosciencesAURA0.4% of the fund
- Faeth TherapeuticsFTH0.2% of the fund
- Liberty Defense HoldingsDETX0.2% of the fund
- Angel StudiosANGX0.1% of the fund
- SUNation EnergySUNE0.1% of the fund
- Satellos BioscienceMSLE0.1% of the fund
- Opus GeneticsIRD<0.1% of the fund
- Creative RealitiesCREX<0.1% of the fund
- Flotek IndustriesFTK<0.1% of the fund
- Sagimet BiosciencesSGMT<0.1% of the fund
- Fabric.AIFABC<0.1% of the fund
Added
Bought more of a stock they already held.
- Lightpath TechnologiesLPTH3.6% of the fund+25%
- American SuperconductorAMSC3.4% of the fund+19%
- AeroVironmentAVAV2.1% of the fund+12%
- TheRealRealREAL1.8% of the fund+22%
- Arlo TechnologiesARLO1.7% of the fund+16%
- Fennec PharmaceuticalsFENC1.1% of the fund+61%
- Brazil PotashGRO0.9% of the fund+124%
- LovesacLOVE0.9% of the fund+22%
- Red Cat HoldingsRCAT0.8% of the fund+134%
- Abeona TherapeuticsABEO0.8% of the fund+85%
- Tigo EnergyTYGO0.7% of the fund+56%
- Ideal PowerIPWR0.6% of the fund+12%
- PaysignPAYS0.6% of the fund+108%
- Nextdoor HoldingsNXDR0.5% of the fund+23%
- Rani Therapeutics HoldingsRANI0.5% of the fund+15%
- GrandstandGRSD0.4% of the fund+7%
- Forte Biosciences0.4% of the fund+11%
- Modular MedicalMODD0.2% of the fund+20%
- Aquestive TherapeuticsAQST0.2% of the fund+76%
- Black Diamond TherapeuticsBDTX0.2% of the fund+90%
- Nektar TherapeuticsNKTR0.1% of the fund+5%
- Atrium TherapeuticsRNA0.1% of the fund+115%
- OptimizeRxOPRX0.1% of the fund+4%
Cut
Sold some of their stake.
- NlightLASR5.7% of the fund-8%
- VicorVICR4.9% of the fund-48%
- 908 DevicesMASS3.7% of the fund-6%
- CevaCEVA3.3% of the fund-8%
- Definium TherapeuticsDFTX3.2% of the fund-27%
- Aehr Test SystemsAEHR3.1% of the fund-76%
- KopinKOPN3.1% of the fund-32%
- BlackSky TechnologyBKSY2.9% of the fund-30%
- Velo3DVELO2.0% of the fund-33%
- Everspin TechnologiesMRAM1.6% of the fund-64%
- PowerfleetAIOT1.3% of the fund-18%
- Gilat Satellite NetworksGILT1.2% of the fund-55%
- RadcomRDCM1.2% of the fund-4%
- OusterOUST0.9% of the fund-15%
- ASP IsotopesASPI0.9% of the fund-26%
- Natural Gas Services GroupNGS0.7% of the fund-12%
- Citi TrendsCTRN0.7% of the fund-19%
- Spire GlobalSPIR0.7% of the fund-4%
- OwletOWLT0.6% of the fund-38%
- GrowGenerationGRWG0.4% of the fund-8%
- Arbe RoboticsARBE0.4% of the fund-7%
- 5E Advanced MaterialsFEAM0.4% of the fund-4%
- OomaOOMA0.3% of the fund-58%
- Crinetics PharmaceuticalsCRNX0.3% of the fund-15%
- AelumaALMU0.3% of the fund-34%
Sold out
Sold their entire stake.
- MDxHealth SAMDXH-100%
- TriSalus Life SciencesTLSI-100%
- Willow Lane AcquisitionWLAC-100%
- the Real Brokerage-100%
- Beeline HoldingsBLNE-100%
- Aviat NetworksAVNW-100%
- GaiaGAIA-100%
- LSI IndustriesLYTS-100%
- InfuSystem HoldingsINFU-100%
- NextCureNXTC-100%
- Century CasinosCNTY-100%
- Ultra Clean HoldingsUCTT-100%
- MaxCyte-100%
Holdings
- Boost RunBRUN
- Share
- 2.7%
- Value
- $32m
- Shares
- 813,739
New
- TalkspaceTALK
- Share
- 1.7%
- Value
- $20m
- Shares
- 3,826,892
Held
- Elmet GroupELMT
- Share
- 0.6%
- Value
- $7m
- Shares
- 344,853
New
- Forte Biosciences
- Share
- 0.4%
- Value
- $5m
- Shares
- 222,500
+11%
- Crinetics PharmaceuticalsCRNX
- Share
- 0.3%
- Value
- $3m
- Shares
- 85,000
-15%
- Argenx SEARGX
- Share
- 0.2%
- Value
- $2m
- Shares
- 2,500
-33%
- Liberty Defense HoldingsDETX
- Share
- 0.2%
- Value
- $2m
- Shares
- 514,300
New
- Atrium TherapeuticsRNA
- Share
- 0.1%
- Value
- $1m
- Shares
- 107,500
+115%
- Satellos BioscienceMSLE
- Share
- 0.1%
- Value
- $1m
- Shares
- 180,000
New
- Satellos Bioscience, Inc. (Can
- Share
- <0.1%
- Value
- $938,777
- Shares
- 125,000
-42%
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| NlightLASR | 5.7% | $65m | 939,011 | -8% |
| VicorVICR | 4.9% | $57m | 148,981 | -48% |
| 908 DevicesMASS | 3.7% | $42m | 4,879,773 | -6% |
| Lightpath TechnologiesLPTH | 3.6% | $41m | 2,537,522 | +25% |
| American SuperconductorAMSC | 3.4% | $40m | 951,604 | +19% |
| CevaCEVA | 3.3% | $38m | 799,806 | -8% |
| Butterfly NetworkBFLY | 3.2% | $37m | 4,430,593 | Held |
| Definium TherapeuticsDFTX | 3.2% | $37m | 784,800 | -27% |
| Aehr Test SystemsAEHR | 3.1% | $36m | 374,808 | -76% |
| KopinKOPN | 3.1% | $36m | 8,024,062 | -32% |
| BlackSky TechnologyBKSY | 2.9% | $34m | 1,200,000 | -30% |
| Boost RunBRUN | 2.7% | $32m | 813,739 | New |
| ImpinjPI | 2.6% | $30m | 207,018 | Held |
| AeroVironmentAVAV | 2.1% | $24m | 146,908 | +12% |
| Velo3DVELO | 2.0% | $23m | 1,322,066 | -33% |
| BackblazeBLZE | 1.9% | $22m | 1,400,166 | Held |
| TheRealRealREAL | 1.8% | $21m | 1,803,647 | +22% |
| Universal Technical InstituteUTI | 1.8% | $21m | 489,098 | Held |
| TalkspaceTALK | 1.7% | $20m | 3,826,892 | Held |
| Arlo TechnologiesARLO | 1.7% | $20m | 1,466,009 | +16% |
| Everspin TechnologiesMRAM | 1.6% | $18m | 750,000 | -64% |
| Insight Molecular DiagnosticsIMDX | 1.5% | $17m | 2,836,692 | Held |
| Amtech SystemsASYS | 1.4% | $16m | 690,000 | New |
| Strata Critical MedicalSRTA | 1.3% | $15m | 2,821,468 | Held |
| PowerfleetAIOT | 1.3% | $15m | 3,840,463 | -18% |
| Gilat Satellite NetworksGILT | 1.2% | $14m | 1,036,181 | -55% |
| RadcomRDCM | 1.2% | $13m | 951,796 | -4% |
| Fennec PharmaceuticalsFENC | 1.1% | $12m | 1,160,296 | +61% |
| Galaxy DigitalGLXY | 1.1% | $12m | 447,000 | Held |
| Alpha CognitionACOG | 1.0% | $12m | 1,672,168 | Held |
| Brazil PotashGRO | 0.9% | $11m | 5,000,000 | +124% |
| Palvella TherapeuticsPVLA | 0.9% | $11m | 69,416 | Held |
| LovesacLOVE | 0.9% | $10m | 610,402 | +22% |
| OusterOUST | 0.9% | $10m | 157,435 | -15% |
| ASP IsotopesASPI | 0.9% | $10m | 1,581,490 | -26% |
| SOPHiA GENETICS SASOPH | 0.9% | $10m | 1,700,000 | New |
| GenasysGNSS | 0.8% | $10m | 5,649,544 | Held |
| Red Cat HoldingsRCAT | 0.8% | $9m | 874,460 | +134% |
| Abeona TherapeuticsABEO | 0.8% | $9m | 1,486,130 | +85% |
| SCHMID GroupSHMD | 0.8% | $9m | 1,388,976 | New |
| Natural Gas Services GroupNGS | 0.7% | $8m | 189,732 | -12% |
| Spruce BiosciencesSPRB | 0.7% | $8m | 146,988 | New |
| Tigo EnergyTYGO | 0.7% | $8m | 3,347,933 | +56% |
| Citi TrendsCTRN | 0.7% | $8m | 134,127 | -19% |
| Spire GlobalSPIR | 0.7% | $8m | 413,522 | -4% |
| LantronixLTRX | 0.6% | $7m | 1,250,000 | New |
| Ideal PowerIPWR | 0.6% | $7m | 1,346,244 | +12% |
| OwletOWLT | 0.6% | $7m | 1,225,353 | -38% |
| Elmet GroupELMT | 0.6% | $7m | 344,853 | New |
| Mayville Engineering CompanyMEC | 0.6% | $7m | 180,000 | New |
| Lifeway FoodsLWAY | 0.6% | $7m | 223,000 | New |
| PaysignPAYS | 0.6% | $7m | 800,965 | +108% |
| ProgynyPGNY | 0.6% | $6m | 220,000 | Held |
| Destination XL GroupDXLG | 0.5% | $6m | 9,399,297 | Held |
| Nextdoor HoldingsNXDR | 0.5% | $6m | 2,655,204 | +23% |
| Rani Therapeutics HoldingsRANI | 0.5% | $6m | 7,500,000 | +15% |
| AllotALLT | 0.5% | $6m | 624,700 | Held |
| Reservoir MediaRSVR | 0.5% | $5m | 545,453 | Held |
| NeoVoltaNEOV | 0.4% | $5m | 1,645,557 | New |
| GrandstandGRSD | 0.4% | $5m | 2,667,343 | +7% |
| Forte Biosciences | 0.4% | $5m | 222,500 | +11% |
| GrowGenerationGRWG | 0.4% | $5m | 3,098,410 | -8% |
| Arbe RoboticsARBE | 0.4% | $5m | 5,506,444 | -7% |
| SANUWAVE HealthSNWV | 0.4% | $5m | 454,550 | Held |
| OrthopediatricsKIDS | 0.4% | $5m | 237,169 | Held |
| 5E Advanced MaterialsFEAM | 0.4% | $4m | 3,126,384 | -4% |
| Eledon PharmaceuticalsELDN | 0.4% | $4m | 1,100,000 | Held |
| Aura BiosciencesAURA | 0.4% | $4m | 591,285 | New |
| OomaOOMA | 0.3% | $3m | 173,820 | -58% |
| Crinetics PharmaceuticalsCRNX | 0.3% | $3m | 85,000 | -15% |
| Opko HealthOPK | 0.3% | $3m | 2,110,000 | Held |
| AelumaALMU | 0.3% | $3m | 131,404 | -34% |
| American Public EducationAPEI | 0.2% | $3m | 53,500 | Held |
| Hippo HoldingsHIPO | 0.2% | $3m | 100,000 | Held |
| Faeth TherapeuticsFTH | 0.2% | $3m | 111,343 | New |
| NkartaNKTX | 0.2% | $3m | 906,000 | Held |
| Xtant Medical HoldingsXTNT | 0.2% | $3m | 5,976,910 | Held |
| Benitec BiopharmaBNTC | 0.2% | $3m | 187,977 | Held |
| Argenx SEARGX | 0.2% | $2m | 2,500 | -33% |
| Alto NeuroscienceANRO | 0.2% | $2m | 80,000 | -53% |
| Liberty Defense HoldingsDETX | 0.2% | $2m | 514,300 | New |
| Modular MedicalMODD | 0.2% | $2m | 441,095 | +20% |
| Aquestive TherapeuticsAQST | 0.2% | $2m | 475,400 | +76% |
| Abacus Global ManagementABX | 0.2% | $2m | 177,772 | Held |
| Black Diamond TherapeuticsBDTX | 0.2% | $2m | 1,000,000 | +90% |
| DHI GroupDHX | 0.2% | $2m | 497,698 | Held |
| Angel StudiosANGX | 0.1% | $2m | 458,379 | New |
| SUNation EnergySUNE | 0.1% | $2m | 820,000 | New |
| SAB BiotherapeuticsSABS | 0.1% | $1m | 375,000 | -6% |
| Nektar TherapeuticsNKTR | 0.1% | $1m | 20,925 | +5% |
| Atrium TherapeuticsRNA | 0.1% | $1m | 107,500 | +115% |
| Satellos BioscienceMSLE | 0.1% | $1m | 180,000 | New |
| OptimizeRxOPRX | 0.1% | $1m | 240,421 | +4% |
| Aytu BiopharmaAYTU | 0.1% | $1m | 619,574 | Held |
| Anteris Technologies GlobalAVR | <0.1% | $1m | 115,000 | Held |
| PepGenPEPG | <0.1% | $1m | 600,000 | -67% |
| CryoportCYRX | <0.1% | $959,443 | 61,111 | Held |
| Opus GeneticsIRD | <0.1% | $955,945 | 232,590 | New |
| Satellos Bioscience, Inc. (Can | <0.1% | $938,777 | 125,000 | -42% |
| Creative RealitiesCREX | <0.1% | $826,000 | 200,000 | New |
Showing the largest 100 of 106.
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 29.2% since 30 June 2025.
Where the money is
Technology43.9%
Health care25.0%
Industrials17.2%
Retail & consumer7.3%
Materials2.2%
Financial services1.5%
Media & telecom0.9%
Energy0.7%
Everyday goods0.6%
Other0.7%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.